ArticleBiotechnology and bioengineering2025
Ultrasound Control of Gene Expression in Human iPSCs via Heat Shock Promoters.
Article in Biotechnology and bioengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Inducible systems are crucial tools in biomedical research, offering researchers spatiotemporal control at the cellular level. A promising development in this field is the use of focused ultrasound for controlling gene expression using heat shock promoters (HSPs). Focused ultrasound-induced mild hyperthermia activates the cellular heat shock response, which in turn activates HSPs and subsequently drives gene expression. Here, we utilized a Cre/LoxP system where each HSP drives Cre expression to investigate inducible gene expression with HSPs. Cre-mediated excision at the AAVS1 knock-in cassette results in constitutive expression of GFP. We assessed the performance of six HSPs in human induced pluripotent stem cells (hiPSCs). HSP16F and synHSPB'3 were the most effective, showing 27.7% and 33.5% GFP positivity, respectively, following 1 h of pulsed 42°C incubations. This contrasts with 0.6% and 3.5% GFP positivity at 37°C, indicating 45.9- and 9.7-fold increases, respectively. Increasing the number of HSP-Cre transposons did not significantly affect HSP16F but did enhance synHSPB'3, demonstrating its tunability. We then applied focused ultrasound to elevate the temperature to 42°C, resulting in 18.6% and 45.6% GFP positivity for HSP16F and synHSPB'3, respectively, compared to 0.3% and 6.2% at 37°C. Our design requires only a single, brief heat shock treatment to achieve permanent gene expression, enhancing its safety and feasibility for in vivo applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.